chr7-142750635-C-T

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6_Very_StrongBP7

The NM_002769.5(PRSS1):​c.121C>T​(p.Leu41Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L41L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00035 ( 0 hom., cov: 37)
Exomes 𝑓: 0.00018 ( 1 hom. )
Failed GnomAD Quality Control

Consequence

PRSS1
NM_002769.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.55

Publications

4 publications found
Variant links:
Genes affected
PRSS1 (HGNC:9475): (serine protease 1) This gene encodes a trypsinogen, which is a member of the trypsin family of serine proteases. This enzyme is secreted by the pancreas and cleaved to its active form in the small intestine. It is active on peptide linkages involving the carboxyl group of lysine or arginine. Mutations in this gene are associated with hereditary pancreatitis. This gene and several other trypsinogen genes are localized to the T cell receptor beta locus on chromosome 7. [provided by RefSeq, Jul 2008]
PRSS1 Gene-Disease associations (from GenCC):
  • hereditary chronic pancreatitis
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, PanelApp Australia, Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 7-142750635-C-T is Benign according to our data. Variant chr7-142750635-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 416607.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.55 with no splicing effect.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRSS1NM_002769.5 linkc.121C>T p.Leu41Leu synonymous_variant Exon 2 of 5 ENST00000311737.12 NP_002760.1 P07477

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRSS1ENST00000311737.12 linkc.121C>T p.Leu41Leu synonymous_variant Exon 2 of 5 1 NM_002769.5 ENSP00000308720.7 P07477

Frequencies

GnomAD3 genomes
AF:
0.000352
AC:
50
AN:
142160
Hom.:
0
Cov.:
37
show subpopulations
Gnomad AFR
AF:
0.000314
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000142
Gnomad ASJ
AF:
0.000307
Gnomad EAS
AF:
0.000200
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000203
Gnomad MID
AF:
0.00347
Gnomad NFE
AF:
0.000483
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000115
AC:
28
AN:
243904
AF XY:
0.0000835
show subpopulations
Gnomad AFR exome
AF:
0.000441
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000172
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000182
AC:
251
AN:
1380674
Hom.:
1
Cov.:
82
AF XY:
0.000177
AC XY:
122
AN XY:
689648
show subpopulations
African (AFR)
AF:
0.000523
AC:
16
AN:
30608
American (AMR)
AF:
0.00
AC:
0
AN:
42446
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25046
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39404
South Asian (SAS)
AF:
0.0000353
AC:
3
AN:
84876
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52426
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5646
European-Non Finnish (NFE)
AF:
0.000199
AC:
208
AN:
1042622
Other (OTH)
AF:
0.000417
AC:
24
AN:
57600
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
17
35
52
70
87
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000351
AC:
50
AN:
142262
Hom.:
0
Cov.:
37
AF XY:
0.000244
AC XY:
17
AN XY:
69662
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000314
AC:
12
AN:
38264
American (AMR)
AF:
0.000142
AC:
2
AN:
14072
Ashkenazi Jewish (ASJ)
AF:
0.000307
AC:
1
AN:
3256
East Asian (EAS)
AF:
0.000201
AC:
1
AN:
4982
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4558
European-Finnish (FIN)
AF:
0.000203
AC:
2
AN:
9850
Middle Eastern (MID)
AF:
0.00373
AC:
1
AN:
268
European-Non Finnish (NFE)
AF:
0.000483
AC:
31
AN:
64180
Other (OTH)
AF:
0.00
AC:
0
AN:
1972
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.357
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0573
Hom.:
0

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary pancreatitis Benign:3
Feb 28, 2015
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Oct 19, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Feb 12, 2016
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
12
DANN
Benign
0.69
PhyloP100
2.5
PromoterAI
0.013
Neutral
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs369646357; hg19: chr7-142458486; COSMIC: COSV61191036; COSMIC: COSV61191036; API